by Tracy Thurman, Activist Post:
In my previous articles, we looked at the global war on farmers, the organizations pushing for the Great Food Reset, the tactics used to foist these changes on the public, and the projects underway to remove your access to healthy, farm-fresh foods. Today we will delve into the contentious issue of vaccines in the food supply.
Accurate information on this topic is not easy to find. The USDA and drug developers aren’t required to release any information on veterinary drugs in the development pipeline, so independent detectives are left searching through peer-reviewed papers, university publications, USDA contracts, grant notifications, company white papers, and university websites to learn what is on the horizon. This system is far from transparent, and frankly, I don’t think that’s an accident.
TRUTH LIVES on at https://sgtreport.tv/
Before any vaccine technology is used on humans, it is usually tried in the veterinary market first due to the incredibly lax regulations. Knowing this, it should come as no surprise that our food animals had been receiving mRNA injections for years before the Covid vaccine rollout.
Around 2014, the USDA granted a conditional license for an mRNA vaccine for use in pigs for Porcine Epidemic Diarrhea Virus. This is equivalent to emergency use authorization and gets around the USDA’s vaccine licensing and authorization process.
In 2015, Merck bought Harrisvaccines to acquire their RNA platform. Merck’s 2015 press release stated that this “RNA Particle technology…represents a breakthrough in vaccine development. It also has a highly versatile production platform able to target a wide range of viruses and bacteria. Pathogens are collected from a farm, and specific genes are sequenced and inserted into RNA particles, making safe, potent vaccines able to provide herd-specific protection.”
Introduced in 2018, Sequivity is Merck’s RNA vaccine platform built on the Harrisvaccines technology. These RNA injections are already in use in pigs. They are customized for different viruses, and each customized injection undergoes no new safety testing; new formulations are deployed immediately. Pork you are eating from the supermarket is already likely treated with these gene therapies.
In 2016, BioNtech and Bayer partnered to develop veterinary mRNA vaccines using Bayer’s veterinary knowledge and the BioNtech MRNA platform (the one used for the Pfizer Covid shot). Given the intervening years for development, there may be a host of new mRNA livestock shots released in the near future.
In October 2021, Iowa State University began a project testing a novel mRNA vaccine against RSV infections in cows, in the form of a subcutaneous implant that continuously releases mRNA into the cow. The anticipated completion date for the study is 2026.
If you think mRNA vaccines are the only problem, think again: according to a 2021 paper published in Frontiers in Veterinary Science, DNA, RNA, and recombinant viral-vector vaccines are all in development. They are touted as capable of quick deployment: no time for pesky safety testing, let alone time to see if humans who consume meat from these animals suffer any long-term health effects. The paper also points out that farmed salmon are already receiving multiple DNA injections for various diseases.
According to Merck’s Veterinary Manual, experimental DNA vaccines have been produced against avian influenza, rabies, bovine viral diarrhea virus, porcine herpesvirus, bovine herpesvirus-1, foot-and-mouth disease, and other veterinary viruses.
